title: Modulation of transduced erythropoietin expression by iron.
abstract: OBJECTIVE
  Future prospects for gene therapy of chronic anemias involve expression of the erythropoietin transgene, which is regulated by oxygen tension. However, other factors such as cytokines or the iron load of erythropoietin-expressing cells can concomitantly modulate transgene expression, as shown for the expression of the endogenous erythropoietin gene in human cell lines and in animals. We tested the effects of iron overload or depletion on the expression of the mouse erythropoietin transgene (cDNA), driven by the hypoxia-regulated phosphoglycerate kinase 1 promoter.
  
  
  METHODS
  Retrovirally transduced mouse cells (C3H fibroblasts or C2C12 myoblasts) were cultured in normoxia (room air, O2: 21%) or hypoxia (O2: 1.5%) in the presence or absence of hemin (an iron donor) or deferiprone (an iron chelator), both of which easily enter the cell.
  
  
  RESULTS
  Hemin inhibited the hypoxia-induced expression of the transgene. In contrast, deferiprone enhanced the hypoxia-induced expression of the erythropoietin transgene and induced its expression in normoxia.
  
  
  CONCLUSIONS
  These results show that, in addition to oxygen partial pressure, the intracellular iron content is critical in the modulation of hypoxia-regulated erythropoietin transgene expression.
authors.affiliation: Laboratory of Experimental Gene Therapy, Institut Universitaire d'Hématologie-Centre Hayem, Hôpital Saint-Louis, Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Dalle
authors.forename: E
authors.initials: E
authors.lastname: Payen
authors.forename: Y
authors.initials: Y
authors.lastname: Beuzard
mesh_terms: D000818:Animals; D002460:Cell Line; D000077543:Deferiprone; D004921:Erythropoietin / Q000096:biosynthesis* / Q000235:genetics*; D005786:Gene Expression Regulation / Q000187:drug effects*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006427:Hemin / Q000494:pharmacology; D006801:Humans; D007501:Iron / Q000494:pharmacology*; D007502:Iron Chelating Agents / Q000494:pharmacology; D051379:Mice; D008809:Mice, Inbred C3H; D010101:Oxygen Consumption; D011728:Pyridones / Q000494:pharmacology; D019076:Transgenes
chemical_list: D007502:Iron Chelating Agents; D011728:Pyridones; D004921:Erythropoietin; D000077543:Deferiprone; D006427:Hemin; D007501:Iron